摘要
目的比较瑞通立和尿激酶用于急性心肌梗死溶栓治疗的效果和不良反应。方法将我院120例接受溶栓治疗的急性心肌梗死患者随机分成2组,瑞通立组60例,尿激酶组60例。统计2组的血管开通率和出血发生率。结果瑞通立组血管总开通率为81.7%,尿激酶组总开通率为38.3%,2组比较差异具有统计学意义(P<0.05)。2组出血发生率比较差异无统计学意义(P>0.05)。结论瑞通立治疗急性心肌梗死疗效优于尿激酶,尤其在发病早期溶栓效果更好。
Objective To compare the effect of Riverstone state and urokinase in thrombolytic therapy for acute myocardial infarction and adverse reaction. Methods The clinical data of 120 patients with acute myocardial infarction treated by thrombolytic therapy. Divided into two groups,60 cases of Li Riverstone group,Urokinase group 60 cases.Tatistics of two groups of blood vessel patency rate and bleeding incidence rate. Results Riverstone vascular group total patency rate was 81.7%,Urokinase group total open rate was 38.3%,two groups of comparisons,the difference is statistically significant(P<0.05).Riverstone state group and the Urokinase group bleeding rate had no significant difference(P>0.05).Conclusion The curative effect in the treatment of acute myocardial infarction Riverstone therapy better than the UK,especially in the early onset of thrombolytic effect is better.
出处
《基层医学论坛》
2016年第S1期1-3,共3页
The Medical Forum
关键词
心肌梗死
溶栓
瑞通立
尿激酶
疗效比较
Myocardial infarction
Thrombolysis
Ruitongli
Urokinase
Curative comparison
